IRadimed Corporation has provided guidance for third quarter 2021 and full year 2021. For the third quarter 2021, the Company expects to report revenue of $10.3 million to $10.5 million, GAAP diluted earnings per share of $0.14 to $0.15. For the year, the Company maintains its full year 2021 guidance and expects to report revenue of $40.0 million to $40.4 million. The Company updated its full year earnings guidance and now expects GAAP diluted earnings per share of $0.53 to $0.55.